Search research articles
Contact Us
Filters
Showing results (61-70 of 93) with videos related to
Page
of 10
Sort By:
Journal of Neurological Surgery. Part B, Skull Base
|
December 31, 2020
Loss of <i>SMARCB1</i> Expression Confers Poor Prognosis to Sinonasal Undifferentiated Carcinoma
Chandala Chitguppi, Mindy R Rabinowitz, Jennifer Johnson, et al.
Journal of Hematology & Oncology
|
September 25, 2016
Immune biomarkers of treatment failure for a patient on a phase I clinical trial of pembrolizumab plus radiotherapy
Gregory S Alexander, Joshua D Palmer, Madalina Tuluc, et al.
Head & Neck
|
September 13, 2019
Evaluation of oncologic outcomes in head and neck cancer patients ≥80 years old based on adherence to NCCN guideline for postoperative adjuvant treatment
Dylan Roden, Kelly Daniels, James Metkus, et al.
Advances in Radiation Oncology
|
July 12, 2024
Association Between Time From Surgery to Radiation Therapy and Multimodality Treatment Outcomes in HPV+ Head and Neck Cancer: A Multi-Institutional Cohort Experience
Muneeb Niazi, Ryan Miller, Ryann Kolb, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
March 4, 2019
Phase I trial of alisertib with concurrent fractionated stereotactic re-irradiation for recurrent high grade gliomas
Andrew Song, David W Andrews, Maria Werner-Wasik, et al.
Biomed Research International
|
January 19, 2016
Prognostic Indications of Elevated MCT4 and CD147 across Cancer Types: A Meta-Analysis
Cory D Bovenzi, James Hamilton, Patrick Tassone, et al.
International Journal of Radiation Oncology, Biology, Physics
|
June 19, 2012
Assessing the value of an optional radiation oncology clinical rotation during the core clerkships in medical school
Nicholas G Zaorsky, Theresa M Malatesta, Robert B Den, et al.
International Journal of Radiation Oncology, Biology, Physics
|
September 26, 2023
A Phase 1 Study of the DNA-PK Inhibitor Peposertib in Combination With Radiation Therapy With or Without Cisplatin in Patients With Advanced Head and Neck Tumors
Michael Samuels, Johan Falkenius, Voichita Bar-Ad, et al.
Journal of Neuro-Oncology
|
May 31, 2015
Re-resection for recurrent high-grade glioma in the setting of re-irradiation: more is not always better
Joshua D Palmer, Joshua Siglin, Kosj Yamoah, et al.
International Journal of Radiation Oncology, Biology, Physics
|
August 2, 2025
Phase 2 Study of Low-Dose Paclitaxel and Cisplatin in Combination With Split-Course Concomitant Twice-Daily Reirradiation in Recurrent Squamous Cell Carcinoma of the Head and Neck: Long-term Follow-up of NRG Oncology Radiation Therapy Oncology Group Protocol 9911
Corey J Langer, Jonathan Harris, Eric M Horwitz, et al.
Page
of 10
Search research articles
Search
Showing results (61-70 of 93) with videos related to
Sort By:
Page
of 10
Journal of Neurological Surgery. Part B, Skull Base
|
December 31, 2020
Loss of <i>SMARCB1</i> Expression Confers Poor Prognosis to Sinonasal Undifferentiated Carcinoma
Chandala Chitguppi, Mindy R Rabinowitz, Jennifer Johnson, et al.
Journal of Hematology & Oncology
|
September 25, 2016
Immune biomarkers of treatment failure for a patient on a phase I clinical trial of pembrolizumab plus radiotherapy
Gregory S Alexander, Joshua D Palmer, Madalina Tuluc, et al.
Head & Neck
|
September 13, 2019
Evaluation of oncologic outcomes in head and neck cancer patients ≥80 years old based on adherence to NCCN guideline for postoperative adjuvant treatment
Dylan Roden, Kelly Daniels, James Metkus, et al.
Advances in Radiation Oncology
|
July 12, 2024
Association Between Time From Surgery to Radiation Therapy and Multimodality Treatment Outcomes in HPV+ Head and Neck Cancer: A Multi-Institutional Cohort Experience
Muneeb Niazi, Ryan Miller, Ryann Kolb, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
March 4, 2019
Phase I trial of alisertib with concurrent fractionated stereotactic re-irradiation for recurrent high grade gliomas
Andrew Song, David W Andrews, Maria Werner-Wasik, et al.
Biomed Research International
|
January 19, 2016
Prognostic Indications of Elevated MCT4 and CD147 across Cancer Types: A Meta-Analysis
Cory D Bovenzi, James Hamilton, Patrick Tassone, et al.
International Journal of Radiation Oncology, Biology, Physics
|
June 19, 2012
Assessing the value of an optional radiation oncology clinical rotation during the core clerkships in medical school
Nicholas G Zaorsky, Theresa M Malatesta, Robert B Den, et al.
International Journal of Radiation Oncology, Biology, Physics
|
September 26, 2023
A Phase 1 Study of the DNA-PK Inhibitor Peposertib in Combination With Radiation Therapy With or Without Cisplatin in Patients With Advanced Head and Neck Tumors
Michael Samuels, Johan Falkenius, Voichita Bar-Ad, et al.
Journal of Neuro-Oncology
|
May 31, 2015
Re-resection for recurrent high-grade glioma in the setting of re-irradiation: more is not always better
Joshua D Palmer, Joshua Siglin, Kosj Yamoah, et al.
International Journal of Radiation Oncology, Biology, Physics
|
August 2, 2025
Phase 2 Study of Low-Dose Paclitaxel and Cisplatin in Combination With Split-Course Concomitant Twice-Daily Reirradiation in Recurrent Squamous Cell Carcinoma of the Head and Neck: Long-term Follow-up of NRG Oncology Radiation Therapy Oncology Group Protocol 9911
Corey J Langer, Jonathan Harris, Eric M Horwitz, et al.
Page
of 10